Abbott Laboratories Share Price
Equities
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.09 USD | -2.39% |
|
-4.62% | +7.94% |
| 05/12 | PRESS DIGEST-New York Times business news - December 5 | RE |
| 04/12 | Abbott Launches Two New Ensure Max Protein Shakes to Tap into Growing Muscle Health Movement | CI |
| Capitalization | 21TCr 18TCr 17TCr 16TCr 29TCr 19,13900Cr 32TCr 1,99900Cr 77TCr 9,03600Cr 80TCr 78TCr 33,10700Cr | P/E ratio 2025 * |
30.7x | P/E ratio 2026 * | 26.6x |
|---|---|---|---|---|---|
| Enterprise value | 22TCr 19TCr 17TCr 16TCr 30TCr 19,48800Cr 33TCr 2,03600Cr 79TCr 9,20100Cr 81TCr 79TCr 33,71100Cr | EV / Sales 2025 * |
4.84x | EV / Sales 2026 * | 4.42x |
| Free-Float |
86.65% | Yield 2025 * |
1.94% | Yield 2026 * | 2.06% |
Last Transcript: Abbott Laboratories
| 1 day | -2.39% | ||
| 1 week | -4.62% | ||
| Current month | -5.28% | ||
| 1 month | -3.38% | ||
| 3 months | -7.65% | ||
| 6 months | -8.60% | ||
| Current year | +7.94% |
| 1 week | 121.71 |  | 127.56 |
| 1 month | 121.71 | | 132.02 |
| Current year | 110.86 | | 141.23 |
| 1 year | 110.86 | | 141.23 |
| 3 years | 89.67 | | 141.23 |
| 5 years | 89.67 | | 142.6 |
| 10 years | 36 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 51 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 52 | 01/09/2023 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 74 | 10/10/2008 |
Sally Blount
BRD | Director/Board Member | 63 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 66 | 09/12/2011 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 7.18% | 26 M€ | +11.67% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.39% | -4.62% | +5.61% | +14.19% | 22TCr | |
| -0.10% | -2.01% | +20.53% | +30.17% | 13TCr | |
| -0.54% | -6.19% | +38.79% | +98.18% | 6.59TCr | |
| -1.77% | -1.21% | -13.87% | -23.58% | 5.54TCr | |
| -0.48% | +0.53% | +17.37% | +71.18% | 5.2TCr | |
| -0.71% | -0.56% | +21.08% | +37.38% | 2.58TCr | |
| +0.20% | +3.31% | -15.57% | -46.51% | 2.55TCr | |
| -0.84% | +1.63% | +17.63% | -33.20% | 2.41TCr | |
| -0.82% | -1.98% | -23.76% | +18.25% | 2.25TCr | |
| -2.73% | -4.71% | +11.57% | -2.36% | 2.14TCr | |
| Average | -1.03% | -1.54% | +7.94% | +16.37% | 6.4TCr | |
| Weighted average by Cap. | -1.26% | -2.65% | +10.73% | +23.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.47TCr 3.85TCr 3.61TCr 3.36TCr 6.19TCr 4,02700Cr 6.75TCr 42TCr 16TCr 1,90100Cr 17TCr 16TCr 6,96600Cr | 4.82TCr 4.15TCr 3.9TCr 3.62TCr 6.68TCr 4,34700Cr 7.28TCr 45TCr 18TCr 2,05200Cr 18TCr 18TCr 7,52000Cr |
| Net income | 692.84Cr 596.4Cr 559.88Cr 520.45Cr 959.33Cr 62TCr 1.05TCr 6.52TCr 2.53TCr 29TCr 2.6TCr 2.54TCr 1,08000Cr | 799.79Cr 688.46Cr 646.3Cr 600.78Cr 1.11TCr 72TCr 1.21TCr 7.53TCr 2.92TCr 34TCr 3TCr 2.94TCr 1,24700Cr |
| Net Debt | 387.23Cr 333.33Cr 312.92Cr 290.88Cr 536.17Cr 35TCr 584.95Cr 3.65TCr 1.41TCr 16TCr 1.45TCr 1.42TCr 60TCr | 86Cr 74Cr 70Cr 65Cr 119.15Cr 7.76TCr 129.99Cr 810.34Cr 313.79Cr 3.66TCr 322.97Cr 316.06Cr 13TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 122.09 $ | -2.39% | 63,92,018 |
| 05/25/05 | 125.08 $ | -0.26% | 43,61,096 |
| 04/25/04 | 125.40 $ | +0.09% | 52,27,065 |
| 03/25/03 | 125.29 $ | -0.82% | 49,18,925 |
| 02/25/02 | 126.32 $ | -1.32% | 54,79,989 |
Delayed Quote Nyse, December 09, 2025 at 02:31 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition